Addressing the Question of Dermatologic Manifestations of SARS-CoV-2 Infection in the Lower Extremities: A Closer Look at the Available Data and its Implications

Abstract

The first case of SARS-CoV-2 infection, also known as the Coronavirus Disease of 2019 (COVID-19) was reported in December of 2019 by doctors in Wuhan, China.(1) Since then, physicians have reported a peculiar sequelae for the novel coronavirus involving various manifestations and courses of the disease as well as a predilection for morbidity and mortality based on certain pre-existing conditions and age groups. Recently, there has been growing interest in anecdotal findings of skin manifestations by several healthcare providers who are postulating a possible correlation to COVID-19.